BioCentury | Aug 2, 2012
Strategy

AZ goes APOE

...alliance is "focused on the biology of the genetic predisposition for AD by APOE4," said Michael Wood...
BioCentury | Nov 12, 2005
Top Story

Sangamo raises $20.5 million

...at $3.85, and $1 million through the sale of 236,000 SGMO shares at $4.24 to Michael Wood...
BioCentury | Mar 14, 2005
Company News

Cubist board of directors update

...Cubist Pharmaceuticals Inc. (CBST), Lexington, Mass. Business: Infectious Appointed: Michael Wood, retired president emeritus of the Mayo...
BioCentury | Apr 17, 2000
Finance

Star search

...Joseph Dougherty, whose coverage included QLT PhotoTherapeutics (TSE:QLT; QLTI), Gilead (GILD) and Trimeris (TRMS); and Michael Wood...
Items per page:
1 - 4 of 4
BioCentury | Aug 2, 2012
Strategy

AZ goes APOE

...alliance is "focused on the biology of the genetic predisposition for AD by APOE4," said Michael Wood...
BioCentury | Nov 12, 2005
Top Story

Sangamo raises $20.5 million

...at $3.85, and $1 million through the sale of 236,000 SGMO shares at $4.24 to Michael Wood...
BioCentury | Mar 14, 2005
Company News

Cubist board of directors update

...Cubist Pharmaceuticals Inc. (CBST), Lexington, Mass. Business: Infectious Appointed: Michael Wood, retired president emeritus of the Mayo...
BioCentury | Apr 17, 2000
Finance

Star search

...Joseph Dougherty, whose coverage included QLT PhotoTherapeutics (TSE:QLT; QLTI), Gilead (GILD) and Trimeris (TRMS); and Michael Wood...
Items per page:
1 - 4 of 4